Atopic Dermatitis Technology

Current treatments for atopic dermatitis (a chronic inflammatory skin disease) only treat the symptoms and not the root cause of the disease. 360ip’s partner has developed a novel treatment that is able to suppress and inhibit the disease, targeting the root cause rather than just treating symptoms. The compound developed by the partner has the following key advantages:

Suppresses fibroinflammation by targeting discoidin domain receptor tyrosine kinase

Current treatments only inhibit inflammation

Inhibits fibrotic cell migration

Inhibits focal adhesion & actin stress fiber

Inhibits cell invasion and Akt1 activation

Suppresses activated macrophage signaling